Stocktoria
FENNEC PHARMACEUTICALS INC. FENC
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2001-06-05
FENNEC PHARMACEUTICALS INC. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Raykov Rosty | director | 2026-06-01 | Sell | 9,747 | $9.62 |
| Raykov Rosty | director | 2026-06-01 | Option exercise | 15,597 | $2.45 |
| Evans Terry L | Chief Commercial Officer | 2026-05-31 | Grant | 168 | — |
| Sayad Pierre Sargis | Chief Medical Officer | 2026-05-31 | Grant | 168 | — |
| Hackman Jeffrey S. | Chief Executive Officer | 2026-05-31 | Grant | 1,159 | — |
| Raykov Rosty | director | 2026-05-31 | Grant | 2,778 | — |
| Andrade Robert | CHIEF FINANCIAL OFFICER | 2026-05-31 | Grant | 1,703 | — |
| Cioffi Christiana Marie | Chief Strategy Officer | 2026-05-31 | Grant | 156 | — |
Source: SEC EDGAR filings · CIK 0001211583 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.